Expression of ribosomal S6 kinase 4 in bladder cancer and its correlation with clinicopathological features
{{output}}
Context: Bladder cancer management is challenged by limited therapeutic targets and heterogeneous treatment responses. Ribosomal S6 kinase 4 (RSK4) has been established as an oncogenic driver in several malignancies, although its... ...
